|
ANIX
|
Anixa Biosciences, Inc.
|
US
|
NASDAQ
|
|
ANR
|
Anatara Lifesciences Ltd
|
AU
|
ASX
|
|
ANTH
|
Anthera Pharmaceutic
|
US
|
OTC
|
|
ANVS
|
Annovis Bio, Inc.
|
US
|
NYSE
|
|
APGE
|
Apogee Therapeutics Inc. Common Stock
|
US
|
US
|
|
APLM
|
Apollomics Inc. Class A Ordinary Shares
|
US
|
US
|
|
APLMW
|
Apollomics Inc. Warrant
|
US
|
US
|
|
APLS
|
Apellis Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
APLT
|
Applied Therapeutics, Inc.
|
US
|
NASDAQ
|
|
APM
|
Aptorum Group Limited
|
US
|
NASDAQ
|
|
APRE
|
Aprea Therapeutics, Inc.
|
US
|
NASDAQ
|
|
APTCF
|
Advanced Proteome Therapeutics Corporation
|
US
|
US
|
|
APTO
|
Aptose Biosciences, Inc.
|
US
|
NASDAQ
|
|
APTX
|
Aptinyx Inc.
|
US
|
NASDAQ
|
|
APVO
|
Aptevo Therapeutics Inc.
|
US
|
NASDAQ
|
|
AQB
|
AquaBounty Technologies, Inc.
|
US
|
NASDAQ
|
|
ARAV
|
Aravive, Inc.
|
US
|
NASDAQ
|
|
ARCT
|
Arcturus Therapeutics Ltd.
|
US
|
NASDAQ
|
|
ARDS
|
Aridis Pharmaceuticals Inc.
|
US
|
NASDAQ
|
|
ARDX
|
Ardelyx, Inc.
|
US
|
NASDAQ
|